Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

December 01, 1991; Volume 40,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aksoy, S

    1. You have access
      Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;
  2. Allen, J M

    1. You have access
      Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.
      R J Hughes, M J Howard, J M Allen and P A Insel
      Molecular Pharmacology December 1991, 40 (6) 974-979;

B

  1. Baden, D G

    1. You have access
      Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
      V L Trainer, W J Thomsen, W A Catterall and D G Baden
      Molecular Pharmacology December 1991, 40 (6) 988-994;
  2. Blaustein, M P

    1. You have access
      Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels.
      M P Blaustein, R S Rogowski, M J Schneider and B K Krueger
      Molecular Pharmacology December 1991, 40 (6) 932-942;
  3. Branchek, T A

    1. You have access
      Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;
  4. Buxton, I L

    1. You have access
      Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
      L B Zhang, B Horowitz and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 943-951;
    2. You have access
      Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
      L B Zhang and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 952-959;

C

  1. Campillo, M

    1. You have access
      Theoretical studies on the histamine H2 receptor: construction of a receptor model based on the structural properties of dimaprit and N alpha-guanylhistamine.
      L Pardo, J Giraldo, M Martín and M Campillo
      Molecular Pharmacology December 1991, 40 (6) 980-987;
  2. Cardozo, M G

    1. You have access
      Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
      M G Cardozo and A J Hopfinger
      Molecular Pharmacology December 1991, 40 (6) 1023-1028;
  3. Catterall, W A

    1. You have access
      Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
      V L Trainer, W J Thomsen, W A Catterall and D G Baden
      Molecular Pharmacology December 1991, 40 (6) 988-994;
  4. Chaudhry, A

    1. You have access
      Molecular cloning and expression of the rat beta 3-adrenergic receptor.
      J G Granneman, K N Lahners and A Chaudhry
      Molecular Pharmacology December 1991, 40 (6) 895-899;
  5. Cornwell, T L

    1. You have access
      Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
      T L Cornwell, K B Pryzwansky, T A Wyatt and T M Lincoln
      Molecular Pharmacology December 1991, 40 (6) 923-931;

D

  1. De Léan, A

    1. You have access
      Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
      J Féthière and A De Léan
      Molecular Pharmacology December 1991, 40 (6) 915-922;
  2. Duman, R S

    1. You have access
      Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;

E

  1. Eskuri, S

    1. You have access
      Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;

F

  1. Féthière, J

    1. You have access
      Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
      J Féthière and A De Léan
      Molecular Pharmacology December 1991, 40 (6) 915-922;

G

  1. Gee, K W

    1. You have access
      Gamma-aminobutyric acidA receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation.
      K W Gee and N C Lan
      Molecular Pharmacology December 1991, 40 (6) 995-999;
  2. Gibson, V A

    1. You have access
      Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;
  3. Giraldo, J

    1. You have access
      Theoretical studies on the histamine H2 receptor: construction of a receptor model based on the structural properties of dimaprit and N alpha-guanylhistamine.
      L Pardo, J Giraldo, M Martín and M Campillo
      Molecular Pharmacology December 1991, 40 (6) 980-987;
  4. Graham, R M

    1. You have access
      Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.
      D M Perez, M T Piascik and R M Graham
      Molecular Pharmacology December 1991, 40 (6) 876-883;
  5. Granneman, J G

    1. You have access
      Molecular cloning and expression of the rat beta 3-adrenergic receptor.
      J G Granneman, K N Lahners and A Chaudhry
      Molecular Pharmacology December 1991, 40 (6) 895-899;

H

  1. Hartig, P R

    1. You have access
      Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;
  2. Henderson, G

    1. You have access
      Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro.
      C Kennedy and G Henderson
      Molecular Pharmacology December 1991, 40 (6) 1000-1005;
  3. Hopfinger, A J

    1. You have access
      Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
      M G Cardozo and A J Hopfinger
      Molecular Pharmacology December 1991, 40 (6) 1023-1028;
  4. Horowitz, B

    1. You have access
      Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
      L B Zhang, B Horowitz and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 943-951;
  5. Hosey, M M

    1. You have access
      Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes.
      C S Mayanil, R M Richardson and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 900-907;
    2. You have access
      Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
      R M Richardson, C S Mayanil and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 908-914;
  6. Howard, M J

    1. You have access
      Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.
      R J Hughes, M J Howard, J M Allen and P A Insel
      Molecular Pharmacology December 1991, 40 (6) 974-979;
  7. Hughes, R J

    1. You have access
      Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.
      R J Hughes, M J Howard, J M Allen and P A Insel
      Molecular Pharmacology December 1991, 40 (6) 974-979;

I

  1. Imakura, Y

    1. You have access
      Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;
  2. Insel, P A

    1. You have access
      Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.
      R J Hughes, M J Howard, J M Allen and P A Insel
      Molecular Pharmacology December 1991, 40 (6) 974-979;

K

  1. Kennedy, C

    1. You have access
      Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro.
      C Kennedy and G Henderson
      Molecular Pharmacology December 1991, 40 (6) 1000-1005;
  2. Krueger, B K

    1. You have access
      Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels.
      M P Blaustein, R S Rogowski, M J Schneider and B K Krueger
      Molecular Pharmacology December 1991, 40 (6) 932-942;

L

  1. Lahners, K N

    1. You have access
      Molecular cloning and expression of the rat beta 3-adrenergic receptor.
      J G Granneman, K N Lahners and A Chaudhry
      Molecular Pharmacology December 1991, 40 (6) 895-899;
  2. Lan, N C

    1. You have access
      Gamma-aminobutyric acidA receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation.
      K W Gee and N C Lan
      Molecular Pharmacology December 1991, 40 (6) 995-999;
  3. Lee, K H

    1. You have access
      Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;
  4. Lincoln, T M

    1. You have access
      Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
      T L Cornwell, K B Pryzwansky, T A Wyatt and T M Lincoln
      Molecular Pharmacology December 1991, 40 (6) 923-931;

M

  1. Macchi, M

    1. You have access
      Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;
  2. Martín, M

    1. You have access
      Theoretical studies on the histamine H2 receptor: construction of a receptor model based on the structural properties of dimaprit and N alpha-guanylhistamine.
      L Pardo, J Giraldo, M Martín and M Campillo
      Molecular Pharmacology December 1991, 40 (6) 980-987;
  3. Mayanil, C S

    1. You have access
      Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes.
      C S Mayanil, R M Richardson and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 900-907;
    2. You have access
      Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
      R M Richardson, C S Mayanil and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 908-914;
  4. McKinney, M

    1. You have access
      Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;
  5. Meeley, M P

    1. You have access
      Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
      S Regunathan, M P Meeley and D J Reis
      Molecular Pharmacology December 1991, 40 (6) 884-888;
  6. Miki, T

    1. You have access
      Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;
  7. Miller, J H

    1. You have access
      Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;

N

  1. Narasimhan, T R

    1. You have access
      Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
      T R Narasimhan, S Safe, H J Williams and A I Scott
      Molecular Pharmacology December 1991, 40 (6) 1029-1035;
  2. Near, J A

    1. You have access
      Purification of a [3H]dihydrotetrabenazine-binding protein from bovine adrenal medulla.
      M S Vincent and J A Near
      Molecular Pharmacology December 1991, 40 (6) 889-894;
  3. Nestler, E J

    1. You have access
      Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;
  4. Nickelson, L

    1. You have access
      Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
      M McKinney, J H Miller, V A Gibson, L Nickelson and S Aksoy
      Molecular Pharmacology December 1991, 40 (6) 1014-1022;

P

  1. Pardo, L

    1. You have access
      Theoretical studies on the histamine H2 receptor: construction of a receptor model based on the structural properties of dimaprit and N alpha-guanylhistamine.
      L Pardo, J Giraldo, M Martín and M Campillo
      Molecular Pharmacology December 1991, 40 (6) 980-987;
  2. Perez, D M

    1. You have access
      Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.
      D M Perez, M T Piascik and R M Graham
      Molecular Pharmacology December 1991, 40 (6) 876-883;
  3. Piascik, M T

    1. You have access
      Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.
      D M Perez, M T Piascik and R M Graham
      Molecular Pharmacology December 1991, 40 (6) 876-883;
  4. Pryzwansky, K B

    1. You have access
      Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
      T L Cornwell, K B Pryzwansky, T A Wyatt and T M Lincoln
      Molecular Pharmacology December 1991, 40 (6) 923-931;

R

  1. Regunathan, S

    1. You have access
      Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
      S Regunathan, M P Meeley and D J Reis
      Molecular Pharmacology December 1991, 40 (6) 884-888;
  2. Reis, D J

    1. You have access
      Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
      S Regunathan, M P Meeley and D J Reis
      Molecular Pharmacology December 1991, 40 (6) 884-888;
  3. Richardson, R M

    1. You have access
      Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes.
      C S Mayanil, R M Richardson and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 900-907;
    2. You have access
      Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
      R M Richardson, C S Mayanil and M M Hosey
      Molecular Pharmacology December 1991, 40 (6) 908-914;
  4. Rimland, J

    1. You have access
      Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;
  5. Rogowski, R S

    1. You have access
      Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels.
      M P Blaustein, R S Rogowski, M J Schneider and B K Krueger
      Molecular Pharmacology December 1991, 40 (6) 932-942;

S

  1. Safe, S

    1. You have access
      Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
      T R Narasimhan, S Safe, H J Williams and A I Scott
      Molecular Pharmacology December 1991, 40 (6) 1029-1035;
  2. Saijoh, K

    1. You have access
      Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;
  3. Sakurai, H

    1. You have access
      Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;
  4. Schechter, L E

    1. You have access
      Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;
  5. Schneider, M J

    1. You have access
      Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels.
      M P Blaustein, R S Rogowski, M J Schneider and B K Krueger
      Molecular Pharmacology December 1991, 40 (6) 932-942;
  6. Scott, A I

    1. You have access
      Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
      T R Narasimhan, S Safe, H J Williams and A I Scott
      Molecular Pharmacology December 1991, 40 (6) 1029-1035;
  7. Shibuya, M

    1. You have access
      Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds.
      H Sakurai, T Miki, Y Imakura, M Shibuya and K H Lee
      Molecular Pharmacology December 1991, 40 (6) 965-973;
  8. Sill, J C

    1. You have access
      Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;
  9. Sweetnam, P

    1. You have access
      Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;

T

  1. Tarara, J

    1. You have access
      Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;
  2. Thomsen, W J

    1. You have access
      Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
      V L Trainer, W J Thomsen, W A Catterall and D G Baden
      Molecular Pharmacology December 1991, 40 (6) 988-994;
  3. Trainer, V L

    1. You have access
      Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
      V L Trainer, W J Thomsen, W A Catterall and D G Baden
      Molecular Pharmacology December 1991, 40 (6) 988-994;

U

  1. Uhl, C

    1. You have access
      Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;

V

  1. Van Dyke, R

    1. You have access
      Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
      J C Sill, C Uhl, S Eskuri, R Van Dyke and J Tarara
      Molecular Pharmacology December 1991, 40 (6) 1006-1013;
  2. Vincent, M S

    1. You have access
      Purification of a [3H]dihydrotetrabenazine-binding protein from bovine adrenal medulla.
      M S Vincent and J A Near
      Molecular Pharmacology December 1991, 40 (6) 889-894;

W

  1. Wadler, S

    1. You have access
      Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolins.
      S Wadler and C P Yang
      Molecular Pharmacology December 1991, 40 (6) 960-964;
  2. Weinshank, R L

    1. You have access
      Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;
  3. Williams, H J

    1. You have access
      Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
      T R Narasimhan, S Safe, H J Williams and A I Scott
      Molecular Pharmacology December 1991, 40 (6) 1029-1035;
  4. Wyatt, T A

    1. You have access
      Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
      T L Cornwell, K B Pryzwansky, T A Wyatt and T M Lincoln
      Molecular Pharmacology December 1991, 40 (6) 923-931;

X

  1. Xin, W

    1. You have access
      Sequence and expression of a neuropeptide Y receptor cDNA.
      J Rimland, W Xin, P Sweetnam, K Saijoh, E J Nestler and R S Duman
      Molecular Pharmacology December 1991, 40 (6) 869-875;

Y

  1. Yang, C P

    1. You have access
      Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolins.
      S Wadler and C P Yang
      Molecular Pharmacology December 1991, 40 (6) 960-964;

Z

  1. Zgombick, J M

    1. You have access
      Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
      J M Zgombick, R L Weinshank, M Macchi, L E Schechter, T A Branchek and P R Hartig
      Molecular Pharmacology December 1991, 40 (6) 1036-1042;
  2. Zhang, L B

    1. You have access
      Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
      L B Zhang, B Horowitz and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 943-951;
    2. You have access
      Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
      L B Zhang and I L Buxton
      Molecular Pharmacology December 1991, 40 (6) 952-959;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 40, Issue 6
1 Dec 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics